US Stock MarketDetailed Quotes

TENX Tenax Therapeutics

Watchlist
  • 5.6100
  • +0.0500+0.90%
Close Dec 20 16:00 ET
  • 5.5900
  • -0.0200-0.36%
Post 16:49 ET
19.12MMarket Cap-0.43P/E (TTM)

Tenax Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-48.35%-3.09M
-228.41%-3.03M
-199.48%-5.17M
48.16%-5.9M
30.45%-1.17M
37.52%-2.08M
73.10%-922.97K
41.28%-1.72M
-4.90%-11.39M
39.00%-1.69M
Net income from continuing operations
-100.84%-3.96M
-223.20%-3.58M
-170.04%-3.8M
30.21%-7.71M
-26.55%-3.23M
32.39%-1.97M
61.33%-1.11M
48.31%-1.41M
65.98%-11.05M
20.61%-2.55M
Operating gains losses
-60.59%14.59K
-53.69%22.06K
68.94%118.79K
-47.03%191.98K
-55.26%37.01K
-57.25%37.01K
-56.71%47.64K
-15.35%70.31K
-31.17%362.41K
-61.80%82.73K
Depreciation and amortization
--0
--0
--0
-93.32%7.57K
-83.88%4.71K
-96.60%969
-96.43%1K
-96.76%895
3.99%113.33K
8.84%29.2K
Other non cash items
-23.44%6.31K
8.59%9.19K
79.23%7.96K
439.43%23.97K
--2.82K
2,116.40%8.25K
470.28%8.46K
71.74%4.44K
-99.98%4.44K
--0
Change In working capital
648.42%852.27K
306.53%513.33K
-279.29%-1.49M
292.92%1.58M
168.22%2.01M
70.67%-155.4K
117.79%126.27K
-19.54%-393.76K
-34.55%-820.86K
276.51%748.09K
-Change in receivables
-148.86%-240.93K
230.93%677.89K
-107.79%-18.29K
14.26%-305.69K
-359.37%-648.53K
-158.75%-96.82K
171.41%204.85K
148.46%234.8K
-1,484.53%-356.52K
101.52%250.04K
-Change in payables and accrued expense
1,965.88%1.09M
-109.43%-164.56K
-134.69%-1.48M
647.71%1.89M
401.71%2.66M
91.18%-58.59K
80.04%-78.58K
-442.26%-628.57K
36.66%-344.95K
430.68%529.21K
-Change in other current liabilities
----
----
----
--0
----
----
----
----
-177.66%-119.39K
-24.08%-31.15K
Cash from discontinued investing activities
Operating cash flow
-48.35%-3.09M
-228.41%-3.03M
-199.48%-5.17M
48.16%-5.9M
30.45%-1.17M
37.52%-2.08M
73.10%-922.97K
41.28%-1.72M
-4.90%-11.39M
39.00%-1.69M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
222.38%2.84K
0
0
1.6K
119.63%1.24K
-100.51%-2.32K
335.57%4K
Net PPE purchase and sale
--0
--0
--0
222.38%2.84K
--0
--0
--1.6K
119.63%1.24K
55.77%-2.32K
335.57%4K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
222.38%2.84K
--0
--0
--1.6K
119.63%1.24K
-100.51%-2.32K
335.57%4K
Financing cash flow
Cash flow from continuing financing activities
53,820.57%92.01M
-34.50%-134.37K
-43.47%7.92M
71.10%13.57M
-8,556.91%-174.47K
-86.43%-171.28K
-101.28%-99.91K
6,026.36%14.01M
-18.55%7.93M
2.06K
Net issuance payments of debt
-62.77%-278.8K
20.09%-134.37K
20.53%-87.73K
---624.3K
---174.47K
-86.43%-171.28K
-22.84%-168.16K
-148.26%-110.4K
--0
--0
Net common stock issuance
32,632.55%91.95M
--0
-53.05%6.52M
----
----
---282.65K
-99.14%68.25K
--13.9M
----
----
Proceeds from stock option exercised by employees
--97
--0
257.32%1.83M
78.97%14.19M
--13.68M
--0
--0
--511.31K
-18.55%7.93M
----
Net other financing activities
----
--0
-20.52%-340.64K
----
----
----
--0
---282.65K
----
----
Cash from discontinued financing activities
Financing cash flow
53,820.57%92.01M
-34.50%-134.37K
-43.47%7.92M
71.10%13.57M
-8,556.91%-174.47K
-86.43%-171.28K
-101.28%-99.91K
6,026.36%14.01M
-18.55%7.93M
--2.06K
Net cash flow
Beginning cash position
-29.94%9.38M
-12.94%12.55M
361.09%9.79M
-61.97%2.12M
192.69%11.14M
85.27%13.39M
402.49%14.41M
-61.97%2.12M
-10.66%5.58M
-54.44%3.81M
Current changes in cash
4,048.03%88.93M
-209.95%-3.17M
-77.57%2.76M
321.62%7.67M
19.83%-1.35M
34.19%-2.25M
-123.42%-1.02M
552.67%12.29M
-419.31%-3.46M
39.26%-1.68M
End cash Position
782.41%98.31M
-29.94%9.38M
-12.94%12.55M
361.09%9.79M
361.09%9.79M
192.69%11.14M
85.27%13.39M
402.49%14.41M
-61.97%2.12M
-61.97%2.12M
Free cash flow
-48.35%-3.09M
-228.41%-3.03M
-199.48%-5.17M
48.17%-5.9M
30.29%-1.17M
37.52%-2.08M
73.10%-922.97K
41.41%-1.72M
-4.87%-11.39M
39.18%-1.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -48.35%-3.09M-228.41%-3.03M-199.48%-5.17M48.16%-5.9M30.45%-1.17M37.52%-2.08M73.10%-922.97K41.28%-1.72M-4.90%-11.39M39.00%-1.69M
Net income from continuing operations -100.84%-3.96M-223.20%-3.58M-170.04%-3.8M30.21%-7.71M-26.55%-3.23M32.39%-1.97M61.33%-1.11M48.31%-1.41M65.98%-11.05M20.61%-2.55M
Operating gains losses -60.59%14.59K-53.69%22.06K68.94%118.79K-47.03%191.98K-55.26%37.01K-57.25%37.01K-56.71%47.64K-15.35%70.31K-31.17%362.41K-61.80%82.73K
Depreciation and amortization --0--0--0-93.32%7.57K-83.88%4.71K-96.60%969-96.43%1K-96.76%8953.99%113.33K8.84%29.2K
Other non cash items -23.44%6.31K8.59%9.19K79.23%7.96K439.43%23.97K--2.82K2,116.40%8.25K470.28%8.46K71.74%4.44K-99.98%4.44K--0
Change In working capital 648.42%852.27K306.53%513.33K-279.29%-1.49M292.92%1.58M168.22%2.01M70.67%-155.4K117.79%126.27K-19.54%-393.76K-34.55%-820.86K276.51%748.09K
-Change in receivables -148.86%-240.93K230.93%677.89K-107.79%-18.29K14.26%-305.69K-359.37%-648.53K-158.75%-96.82K171.41%204.85K148.46%234.8K-1,484.53%-356.52K101.52%250.04K
-Change in payables and accrued expense 1,965.88%1.09M-109.43%-164.56K-134.69%-1.48M647.71%1.89M401.71%2.66M91.18%-58.59K80.04%-78.58K-442.26%-628.57K36.66%-344.95K430.68%529.21K
-Change in other current liabilities --------------0-----------------177.66%-119.39K-24.08%-31.15K
Cash from discontinued investing activities
Operating cash flow -48.35%-3.09M-228.41%-3.03M-199.48%-5.17M48.16%-5.9M30.45%-1.17M37.52%-2.08M73.10%-922.97K41.28%-1.72M-4.90%-11.39M39.00%-1.69M
Investing cash flow
Cash flow from continuing investing activities 000222.38%2.84K001.6K119.63%1.24K-100.51%-2.32K335.57%4K
Net PPE purchase and sale --0--0--0222.38%2.84K--0--0--1.6K119.63%1.24K55.77%-2.32K335.57%4K
Cash from discontinued investing activities
Investing cash flow --0--0--0222.38%2.84K--0--0--1.6K119.63%1.24K-100.51%-2.32K335.57%4K
Financing cash flow
Cash flow from continuing financing activities 53,820.57%92.01M-34.50%-134.37K-43.47%7.92M71.10%13.57M-8,556.91%-174.47K-86.43%-171.28K-101.28%-99.91K6,026.36%14.01M-18.55%7.93M2.06K
Net issuance payments of debt -62.77%-278.8K20.09%-134.37K20.53%-87.73K---624.3K---174.47K-86.43%-171.28K-22.84%-168.16K-148.26%-110.4K--0--0
Net common stock issuance 32,632.55%91.95M--0-53.05%6.52M-----------282.65K-99.14%68.25K--13.9M--------
Proceeds from stock option exercised by employees --97--0257.32%1.83M78.97%14.19M--13.68M--0--0--511.31K-18.55%7.93M----
Net other financing activities ------0-20.52%-340.64K--------------0---282.65K--------
Cash from discontinued financing activities
Financing cash flow 53,820.57%92.01M-34.50%-134.37K-43.47%7.92M71.10%13.57M-8,556.91%-174.47K-86.43%-171.28K-101.28%-99.91K6,026.36%14.01M-18.55%7.93M--2.06K
Net cash flow
Beginning cash position -29.94%9.38M-12.94%12.55M361.09%9.79M-61.97%2.12M192.69%11.14M85.27%13.39M402.49%14.41M-61.97%2.12M-10.66%5.58M-54.44%3.81M
Current changes in cash 4,048.03%88.93M-209.95%-3.17M-77.57%2.76M321.62%7.67M19.83%-1.35M34.19%-2.25M-123.42%-1.02M552.67%12.29M-419.31%-3.46M39.26%-1.68M
End cash Position 782.41%98.31M-29.94%9.38M-12.94%12.55M361.09%9.79M361.09%9.79M192.69%11.14M85.27%13.39M402.49%14.41M-61.97%2.12M-61.97%2.12M
Free cash flow -48.35%-3.09M-228.41%-3.03M-199.48%-5.17M48.17%-5.9M30.29%-1.17M37.52%-2.08M73.10%-922.97K41.41%-1.72M-4.87%-11.39M39.18%-1.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data